⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RLAY News
Relay Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
RLAY
Relay Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Outlines Anticipated 2026 Milestones
globenewswire.com
RLAY
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in March
globenewswire.com
RLAY
Relay Therapeutics to Announce Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights on February 26, 2026
globenewswire.com
RLAY
AI-Powered Relevance Transforms Checkout: Rokt's Measurement-First Approach
prnewswire.com
RLAY
PYPL
FNB
ULTA
M
AMC
UBER
SCL
$207B Market Shift: The Race for Fast Track Approval in Oncology
prnewswire.com
AVBP
ONCY
RLAY
ZLAB
MAIA
Relay Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026
globenewswire.com
RLAY
Relay Therapeutics Announces Zovegalisib Granted Breakthrough Therapy Designation by U.S. FDA for PIK3CA-mutant, HR+/HER2- Advanced Breast Cancer
globenewswire.com
RLAY
Rokt Partners with Cineplex to Bring AI-Powered Relevance to Its Ecommerce Checkout Experience
prnewswire.com
RLAY
Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards
globenewswire.com
ONCY
IMNM
PRLD
CNTX
RLAY